Insider Cluster (2 insiders) ·Filed Aug 21, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $1.5M total
Actionable Insight • Neutral

The insider sales are routine option exercises and sell-to-cover transactions with no informational content. Monitor UTHR's next earnings release for any fundamental changes, but this cluster does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
UTHR ▼ -3.60% at T+20d
NEUTRAL call ✗ call lost -3.60% · α vs SPY -3.32% · entry $513.12 → $494.63
Next anchor: T+60d in 6w
Latest observation: T+27 +9.57% FF3 residual α
Entry anchored
Aug 20, 07:07 PM ET
via 1-min bar
T+1d
-0.05%
call -0.05% · α +0.25%
$512.88
settled 6w ago
T+5d
+0.46%
call +0.46% · α -0.02%
$515.46
settled 5w ago
T+20d
-3.60%
call -3.60% · α -3.32%
$494.63
settled 14d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and EVP Paul Mahon sold a combined ~$1.54M in open-market sales on August 20, 2026, following the exercise of stock options. The sales are routine and tied to option exercises, representing just 0.007% of UTHR's $22.3B market cap, making them immaterial. No bearish signal is warranted given the trivial size and non-cash derivative exercises.

Key Financial Metrics

Direction
selling
Total Value
$1.5M
Insiders
2

Key Facts

  • CEO Rothblatt sold 8,500 shares for ~$4.53M in open-market sales, all tied to exercising 19,000 options at $135.42 and $0 strike.
  • EVP Mahon sold 9,330 shares for ~$3.83M in open-market sales, tied to exercising 10,990 options at $146.03 and $0 strike.
  • Total open-market sales of ~$1.54M represent 0.007% of UTHR's $22.3B market cap — trivial.
  • All sales occurred on the same day (Aug 20, 2026), consistent with a single-day option exercise and sell-to-cover pattern.
  • No 10b5-1 plan or recurring pattern is evident, but the sales are fully explained by option exercises.

Financial Impact

Total open-market sales of ~$1.54M, or 0.007% of market cap — immaterial.

dilution

Risk Factors

  • Insider sales could be misinterpreted as bearish by the market, but the trivial size relative to market cap makes this unlikely.
  • No fundamental risk identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1787378580585
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Closed — Opens in 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 22, 2026